<DOC>
	<DOCNO>NCT00231894</DOCNO>
	<brief_summary>This study approve drug treat type 2 diabetes , effect treat glucose lipid abnormality patient treat olanzapine clozapine , comparison effect drug another treatment lifestyle modification . Patients meet inclusion criterion treat pioglitazone 12 week . They evaluate fast glucose lipid , glucose-tolerance test , neurocognitive battery test verbal memory baseline treatment pioglitazone .</brief_summary>
	<brief_title>Pioglitazone Treatment Lipid Glucose Abnormalities In Patients With Schizophrenia</brief_title>
	<detailed_description>The aim study investigate effect pioglitazone add weight-lifestyle intervention vs. placebo plus lifestyle intervention reverse reduce impaired abnormal triglyceride , HDL glucose metabolism schizophrenic treat clozapine olanzapine . Another aim examine effect impair glucose metabolism verbal memory cognitive function schizophrenic patient treat medication relationship improvement impair glucose metabolism impairment cognitive function . Clozapine olanzapine , two second generation antipsychotic effective treat schizophrenia bipolar disorder , report associate increased incidence diabetic type metabolic abnormality , decrease insulin sensitivity , abnormal glucose tolerance test . This lead development type 2 diabetes also abnormal lipid metabolic level lead atherosclerotic change increase risk cardiovascular disease diabetes related complication . Drug treatment could reduce correct diabetic metabolic change would permit many patient continue receive benefit antipsychotic medication reduce drug-induced comorbidity . Previous research use non-psychotic subject show diabetes impair glucose tolerance associate cognitive impairment , especially verbal memory , provide rationale test whether correction impair glucose metabolism associate cognitive improvement schizophrenic patient .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Cognition Disorders</mesh_term>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Pioglitazone</mesh_term>
	<mesh_term>Antipsychotic Agents</mesh_term>
	<criteria>1 . Patients male female , 1870 yr age , diagnosis schizophrenia schizoaffective disorder , currently treat olanzapine clozapine . 2 . Patients evidence : 1. glucose level indicate least impaired fast glucose : fasting glucose 100 mg/dL 2 hr glucose tolerance test 140 mg/dL , current treatment oral antidiabetic drug history hyperglycemia ; 2 . Triglyceride level &gt; 150 mg/dL and/or HDL level &lt; 40 mg/dL 1 . Diabetes mellitus , type 1 2 . Recent diabetic ketoacidosis ; 3 . Patients currently treat oral antidiabetic drug fast glucose 140 mg/dL [ WHO criteria ] repeat test last three month , random blood glucose &gt; 200 mg/dL plus 2 hr glucose GTT &gt; 200 mg/dL ; ( patient may need immediate treatment antidiabetic drug less certain weightlifestyle treatment would effective treat high glucose level ) ; 4 . Patients active liver disease clinical abnormality need current treatment , liver enzymes ( Alt ) 3 time upper limit normal value chart record last year , patient record positive hepatitis C ; 5 . Congestive heart failure ( Class III IV cardiac status ) history MI medical record ( pioglitazone increase blood volume slightly ) ; 6 . Hematocrit great 10 % normal ( hematocrit may decrease 2 4 % due increase plasma volume ) ; 7 . Female patient current oral contraceptive ( pioglitazone may interfere effect oral contraceptive ) ; 8 . Patients take ketoconazole , 9 . Patients start atorvastatin gemfibrozil past 2 month dose increase atorvastatin last month ( since drug also low triglyceride raise HDL , recent start therapy drug could confound ) . 10 . Patients concomitantly treat aripiprazole ziprasidone .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>April 2010</verification_date>
	<keyword>atypical antipsychotic</keyword>
	<keyword>hyperglycemia</keyword>
	<keyword>triglyceride</keyword>
	<keyword>HDL</keyword>
	<keyword>cholesterol</keyword>
	<keyword>insulin resistance</keyword>
	<keyword>schizophrenia</keyword>
	<keyword>verbal memory</keyword>
</DOC>